Imugene Limited (ASX:IMU) presentation at Ausbiz Investor Connect October 2025
23:12
Imugene Limited (ASX:IMU) presentation at Ausbiz Investor C…
580 views5 months ago
YouTubeImugene Limited
Imugene HER-Vaxx and CF33 platforms feature at ASCO Gastrointestinal Cancers Symposium
Imugene HER-Vaxx and CF33 platforms feature at ASCO Gastroi…
Jan 19, 2023
proactiveinvestors.com.au
Imugene doses first combination patient in lung cancer clinical trial
Imugene doses first combination patient in lung cancer clinical trial
May 31, 2023
proactiveinvestors.com.au
FDA backs Imugene’s azer-cel treatment plan - ICYMI
FDA backs Imugene’s azer-cel treatment plan - ICYMI
4 months ago
proactiveinvestors.com
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
5 months ago
proactiveinvestors.com
Imugene doses first patient in Phase 2 clinical trial
Imugene doses first patient in Phase 2 clinical trial
2 viewsSep 8, 2022
proactiveinvestors.com.au
Imugene with Proactive at ASX Small and Mid Cap Conference
Imugene with Proactive at ASX Small and Mid Cap Conference
Mar 26, 2024
proactiveinvestors.com.au
Imugene fields positive results in Phase 1b trial of azer-cel CAR T th…
Sep 2, 2024
proactiveinvestors.com.au
Imugene doses first patient in “groundbreaking” Phase 1 OASIS …
Oct 26, 2023
proactiveinvestors.com
Imugene chair says company "as strong as ever" amid turbulent glo…
May 23, 2022
proactiveinvestors.com.au
Imugene advances to cohort three of VAXINIA monotherapy dose esc…
Apr 4, 2023
proactiveinvestors.com.au
Imugene raises A$18.2 million in SPP for acquisition of Azer-cel lic…
Sep 25, 2023
proactiveinvestors.com.au
Imugene records positive final safety and efficacy data from Phas…
Jun 27, 2022
proactiveinvestors.com.au
Imugene opens higher as novel cancer-killing virus VAXINIA is gra…
Nov 27, 2023
proactiveinvestors.com.au
Groundbreaking cancer trial: Imugene’s CF33 advances in clini…
Nov 13, 2024
proactiveinvestors.com.au
Imugene advances to combination dosing with Phase 1 onCARlytics …
Mar 11, 2024
proactiveinvestors.com.au
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in i…
Feb 14, 2024
proactiveinvestors.com.au
Imugene reveals new clinical data for HER-Vaxx vaccine showing ca…
Jul 8, 2019
proactiveinvestors.com.au
Imugene highlights azer-cel progress as trial patient enters re…
1 month ago
proactiveinvestors.com.au
Imugene well positioned to deliver 2024 milestones
Dec 29, 2023
proactiveinvestors.com.au
Imugene partners with Kincell Bio; selling cell therapy manufacturin…
Apr 16, 2024
proactiveinvestors.com
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
Oct 26, 2023
proactiveinvestors.co.uk
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Nov 27, 2023
proactiveinvestors.com.au
1:02
Stocks and Sips with Imugene (ASX:IMU)
365 views5 months ago
YouTubeSharewise
Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial …
Dec 5, 2023
proactiveinvestors.com.au
Imugene receives positive early results, including a 'complete resp…
Jan 17, 2024
proactiveinvestors.com.au
Imugene’s Phase 1b Azer-cel trial 57% complete response rate
Feb 14, 2025
proactiveinvestors.com
Imugene has cancer vaccine trial data published in prestigious med…
Feb 25, 2019
proactiveinvestors.com.au
Imugene wins US FDA approval to begin onCARlytics first-in-class cl…
May 18, 2023
proactiveinvestors.com
Imugene secures FDA orphan drug designation for bile tract cancer tr…
Sep 18, 2024
proactiveinvestors.com.au
See more videos
Static thumbnail place holder